Jeronimo
Martinez Garcia
Asociado Ciencias de la Salud
2026
-
Corrigendum to “Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgery” [Gynecol Oncol. 2026 Apr;207:16-22. doi:10.1016/j.ygyno.2026.02.014. Epub 2026 Feb 25. PMID: 41747472] (Gynecologic Oncology (2026) 207 (16–22), (S0090825826008085), (10.1016/j.ygyno.2026.02.014))
Gynecologic Oncology
-
Neoadjuvant Chemotherapy Following Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Retrospective Cohort Study
Cancers, Vol. 18, Núm. 5
-
Rectosigmoidectomy versus pelvic peritonectomy in the management of seromuscular involvement of superficial rectal wall tumors in advanced-stage ovarian cancer at complete interval cytoreductive surgery
Gynecologic Oncology, Vol. 207, pp. 16-22
2025
-
Challenges of Nontherapeutic Laparotomy in Patients with Peritoneal Surface Malignancies Selected for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Cancers, Vol. 17, Núm. 9
-
Combined Hyperthermic Intraperitoneal Chemotherapy and Normothermic Intraperitoneal Chemotherapy Long-Term After Interval Cytoreduction in Ovarian Cancer: A Phase I Clinical Trial (BICOV1)
Cancers, Vol. 17, Núm. 12
-
Peritoneal cancer index in ovarian cancer: what does the surgeon really see?
Clinical and Translational Oncology, Vol. 27, Núm. 11, pp. 4185-4191
2024
-
Systematic Cholecystectomy During Cytoreductive Surgery Plus HIPEC: A Critical Analysis of an Empirical Tradition
Annals of Surgical Oncology, Vol. 31, Núm. 10, pp. 7157-7164
2023
-
HIPEC in Ovarian Cancer Is the Future… and Always Will Be? Results from a Spanish Multicentric Survey
Cancers, Vol. 15, Núm. 13
2022
-
Interval cytoredutive surgery and HIPEC in advanced ovarian cancer with small-bowel disease: results and reflections
Clinical and Translational Oncology, Vol. 24, Núm. 8, pp. 1542-1548
2021
-
Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used
Langenbeck's Archives of Surgery, Vol. 406, Núm. 7, pp. 2449-2456
-
CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients
OncoImmunology, Vol. 10, Núm. 1
-
Characteristics and prognosis of jejunoileal gastrointestinal stromal tumours (GISTs) in the era of imatinib: a comparative study with gastric GISTs
Clinical and Translational Oncology, Vol. 23, Núm. 7, pp. 1368-1376
-
Unresectable GIST liver metastases and liver transplantation: A review and theoretical basis for a new indication
International Journal of Surgery, Vol. 94
-
Urinary and fecal incontinence in patients with advanced ovarian cancer treated with CRS + HIPEC
Surgical Oncology, Vol. 36, pp. 115-119
2020
-
Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy
Clinical and Translational Oncology, Vol. 22, Núm. 6, pp. 852-859
-
Risk factors and management of incisional hernia after cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal surface malignancies
Hernia, Vol. 24, Núm. 2, pp. 257-263
2019
-
Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC
Clinical and Experimental Metastasis, Vol. 36, Núm. 5, pp. 433-439
2017
-
Valor predictivo y pronóstico de la determinación de células tumorales y ADN libre circulantes en plasma en carcinoma epitelial de ovario en estadio avanzado
Valor predictivo y pronóstico de la determinación de células tumorales y ADN libre circulantes en plasma en carcinoma epitelial de ovario en estadio avanzado